BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21689621)

  • 1. Locoregional therapy for hepatocellular carcinoma.
    Guimaraes M; Uflacker R
    Clin Liver Dis; 2011 May; 15(2):395-421, vii-x. PubMed ID: 21689621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventional radiology for hepatocellular carcinoma.
    Loffroy R
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
    Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R
    Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: locoregional and targeted therapies.
    Wong R; Frenette C; Gish R
    Gastroenterol Clin North Am; 2011 Sep; 40(3):599-610. PubMed ID: 21893276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques.
    Hong K; Georgiades CS; Geschwind JF
    Nat Clin Pract Oncol; 2006 Jun; 3(6):315-24. PubMed ID: 16757969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loco-regional treatment of hepatocellular carcinoma.
    Lencioni R
    Hepatology; 2010 Aug; 52(2):762-73. PubMed ID: 20564355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local-regional treatment of hepatocellular carcinoma.
    Lencioni R; Crocetti L
    Radiology; 2012 Jan; 262(1):43-58. PubMed ID: 22190656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Primary Liver Tumors and Liver Metastases, Part 2: Non-Nuclear Medicine Techniques.
    Cornelis FH; Solomon SB
    J Nucl Med; 2018 Dec; 59(12):1801-1808. PubMed ID: 30361378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor effect and indication of chemoembolization using degradable starch microspheres and regional hyperthermia in patients with hepatocellular carcinoma].
    Yoshikawa T; Oyamada H; Ichikawa H; Naito Y; Ueda S; Tainaka K; Itani K; Seto O; Sugino S; Kondo M
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):786-92. PubMed ID: 2550568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter and ablative therapeutic approaches for solid malignancies.
    Liapi E; Geschwind JF
    J Clin Oncol; 2007 Mar; 25(8):978-86. PubMed ID: 17350947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image-guided ablation for hepatocellular carcinoma.
    Lencioni R; Crocetti L
    Recent Results Cancer Res; 2013; 190():181-94. PubMed ID: 22941021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial therapies for hepatocellular carcinoma.
    Sangro B; D'Avola D; IƱarrairaegui M; Prieto J
    Expert Opin Pharmacother; 2011 May; 12(7):1057-73. PubMed ID: 21470073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in the treatment of hepatocellular carcinoma.
    Roh MS
    Curr Opin Oncol; 1990 Aug; 2(4):725-30. PubMed ID: 1965691
    [No Abstract]   [Full Text] [Related]  

  • 14. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
    Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC
    Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive therapies for hepatic malignancy.
    Knab LM; Salem R; Mahvi DM
    Curr Probl Surg; 2013 Apr; 50(4):146-79. PubMed ID: 23507316
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of local ablation therapy following portal embolization therapy for hepatocellular carcinoma with portal vein tumor thrombus].
    Doi K; Beppu T; Ishiko T; Kai K; Maeda K; Nakagawa M; Takahashi M; Egami H; Ogawa M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1702-5. PubMed ID: 14619498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives.
    Kang TW; Lim HK; Cha DI
    World J Gastroenterol; 2018 Dec; 24(47):5331-5337. PubMed ID: 30598578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors.
    Gannon CJ; Curley SA
    Semin Radiat Oncol; 2005 Oct; 15(4):265-72. PubMed ID: 16183480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins?
    Biolato M; Marrone G; Racco S; Di Stasi C; Miele L; Gasbarrini G; Landolfi R; Grieco A
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):356-62. PubMed ID: 20496548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.
    Nicolini A; Martinetti L; Crespi S; Maggioni M; Sangiovanni A
    J Vasc Interv Radiol; 2010 Mar; 21(3):327-32. PubMed ID: 20097098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.